Partner Area
Logo Logo Logo Logo Logo
  • About Vacdiva
  • Work Packages
  • News
  • Vacdiva Activities
  • Our team
  • ASF
    • CURRENT STATUS
    • ASF news
    • DISEASE PROFILE
    • RISKS
    • WHAT DO WE HAVE?
    • WHAT IS NEEDED?
  • About Vacdiva
  • Work Packages
  • News
  • Vacdiva Activities
  • Our team
  • ASF
    • CURRENT STATUS
    • ASF news
    • DISEASE PROFILE
    • RISKS
    • WHAT DO WE HAVE?
    • WHAT IS NEEDED?

Archive

Eurofins Ingenasa participates in the VACDIVA Project, which aims to develop an effective vaccine against African Swine Fever (ASFV) 🇬🇧
20 noviembre, 2019
The first Kick off Meeting of the project VACDIVA 🇪🇸
20 noviembre, 2019
Eurofins Ingenasa participates in the VACDIVA Project, which aims to develop an effective vaccine against African Swine Fever (ASFV)
20 noviembre, 2019
porcicultura.com
China’s pork production could return to normal by 2020 🇪🇸
20 noviembre, 2019
The VACDIVA project for the development of a vaccine against ASF starts 🇪🇸
20 noviembre, 2019
VACDIVA project to develop an ASF vaccine begins 🇪🇸
19 noviembre, 2019
Vacdiva project launched to develop an ASF vaccine 🇪🇸
19 noviembre, 2019
The VACDIVA project for the development of a vaccine against ASF starts 🇪🇸
19 noviembre, 2019
VACDIVA project to develop an ASF vaccine begins 🇪🇸
19 noviembre, 2019
VACDIVA project to develop an ASF vaccine begins 🇪🇸
19 noviembre, 2019
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34

VACDIVA is an Horizon 2020 European Project born with the aim of developing an effective vaccine against African Swine Fever.

Contact

info@vacdiva.eu

Copyright 2019 VACDIVA. All rights reserved
HORIZCIENCE project management
Legal notice | Cookies policy | Privacy policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy